Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

NCT00169195

Conditions
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hôpital Henri Mondor Créteil, France
  • Service d'Hématologie Clinique - CHU Le Bocage Dijon, France
  • Service des Maladies du Sang - CHRU de Lille Lille, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Completed

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

NCT00144807

Conditions
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
  • Polyclinique Bordeaux Nord Bordeaux, France
  • Hôpital Henri Mondor Créteil, France
  • Hématologie CHU de Lille Lille, France
View all 13 locations
View Trial Details
Completed

Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

NCT01236391

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Cll Research and Treatment Program New Hyde Park, New York, United States
  • New York Presbyterian Hospital/Cornell Medical Center New York, United States
View all 18 locations
View Trial Details
Completed

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

NCT01519089

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +30 more
Locations
  • Fukuoka University Hospital Fukuoka, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • JR Sapporo hospital Sapporo, Hokkaido, Japan
  • Kobe University Hospital Chuo-ku, Kobe, Hyōgo, Japan
View all 16 locations
View Trial Details
Completed

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01014208

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Chicago, Illinois, United States
View all 173 locations
View Trial Details

Related conditions